Executives are stepping in after volatility. Here are the
details. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏



 

[Morning Watchlist]

_You are receiving this email because you are subscribed to BEHIND THE
MARKETS. If you no longer wish to receive these emails,
please unsubscribe
[[link removed]] here._

_Prefer to view this content on our website? Click here.
[[link removed]]
_

-------------------------

Dear Fellow Investor,

A PET CARE CEO JUST BOUGHT ABOUT $500,000 OF HIS SKYROCKETING STOCK

If insiders are putting their money where their mouths are, pay close
attention.

CORPORATE INSIDERS, CEOS, CFOS, DIRECTORS, AND KEY EXECUTIVES have a
perspective most investors don’t. They see demand trends in real
time, understand what’s working (and what isn’t), and have
visibility into product pipelines, margin pressures, and strategic
initiatives well before those details show up in quarterly headlines.

That’s why insider buying matters. Executives sell stock for all
sorts of reasons, taxes, diversification, estate planning... but they
typically buy for one reason: THEY BELIEVE THE STOCK IS UNDERVALUED
RELATIVE TO WHAT’S COMING NEXT.

Even more interesting is WHEN INSIDERS BUY AFTER A BIG MOVE, either
into strength (signaling confidence the rally isn’t finished) or
into weakness (signaling the selloff may have gone too far). In
today’s market, WE’RE SEEING MEANINGFUL INSIDER BUYING ACROSS A
RANGE OF INDUSTRIES, from pet health to retail to fintech.

Here are three names worth watching.

-------------------------

COMPANY: ELANCO ANIMAL HEALTH (SYM: ELAN)
A CEO BUYING INTO STRENGTH

Start with ELANCO ANIMAL HEALTH (SYM: ELAN), a pet and livestock
health company that was spun off from Eli Lilly back in 2018.

ELAN has been one of the market’s stronger rebound stories. After
bottoming out in April at around $8 a share, THE STOCK HAS SURGED TO
ABOUT $22.30, and the move may not be over yet.

What makes the latest rally stand out is what happened on December 11:
CEO JEFFREY SIMMONS PAID $478,500 TO BUY 22,000 SHARES at an average
price of $21.75.

That’s not a symbolic purchase. That’s meaningful money, deployed
near recent highs, suggesting Simmons believes the company’s
momentum can continue even after a major run.

Operationally, Elanco has benefited from key product launches,
including a chewable parasite preventative for dogs and an anti-itch
medication, exactly the types of recurring, “must-have” products
that pet owners are often willing to pay for, even when other
discretionary spending gets squeezed.

And the bigger tailwind here is straightforward: Americans spend big
money on their pets, and that spending trend continues to climb.

In 2024, households spent roughly $40 BILLION on vet care and pet
medications alone. Looking forward, spending is projected to surge
further. Estimates also suggest Americans will spend about $157
BILLION ON THEIR PETS BY THE END OF 2025, with projections reaching
almost $200 BILLION BY 2030.

Those are substantial catalysts for companies positioned in veterinary
care, pet pharmaceuticals, and preventative treatments—especially
businesses that can successfully launch differentiated products and
build recurring demand.

WHAT TO WATCH NEXT:
For ELAN, the key question is whether the company can keep converting
product traction into sustained revenue growth and margin improvement.
If that happens, insider buying into strength could prove to be an
early confirmation that the next leg higher is still on the table.

-------------------------

_TradeSmith_

Maryland's "ROBIN HOOD":
CEO's Company Creates Device That 'Steals' Wall Street's Edge
[chip]
[[link removed]]

TradeSmith's Keith Kaplan is Wall Street's worst nightmare. His
Baltimore-based company has engineered a device that helps regular
folks decide when to buy and sell based on mathematics, not emotion.
"We're leveling the playing field," says the disruptive CEO.
[BUTTON]
[[link removed]]
-------------------------

Company: Bath & Body Works (SYM: BBWI)
BEATEN DOWN… BUT INSIDERS ARE STEPPING IN

It’s been a rough year for the stock. BBWI fell from roughly $40
earlier in the year to a low near $14.28. Even after rebounding to
about $19.79, it’s still deep in “repair mode” after getting hit
on earnings and broader concerns around consumer spending.

But here’s the change in tone: insiders are buying, and not just one
person.

On November 21, director Lucy Brady bought just over 3,469 SHARES AT
$14.40. Huntington Bancshares CEO Stephen Steinour bought 6,700 SHARES
AT $14.86. Former Mastercard executive Francis Hondal bought 3,343
SHARES AROUND $15. Hershey VP and CFO Steven Voskuil bought 20,000
SHARES AT ABOUT $15.04.

Then on November 24, BOARD CHAIR SARAH NASH PURCHASED 10,000 SHARES AT
$15.58, and SIGNET JEWELERS CEO JAMES SYMANCYK BOUGHT 22,500 SHARES AT
ROUGHLY $15.58.

That’s a notable cluster of insider buying around the same price
zone.

Cluster buying matters because it reduces the odds this is simply one
person’s opinion. When multiple insiders independently buy within
days of each other, especially after a sharp drop, it often signals
internal conviction that the market is mispricing the business.

In retail, sentiment can swing violently. A single disappointing
quarter can compress the valuation, even if the underlying brand
remains strong and cash generation remains meaningful. When insiders
step in at depressed prices, they’re effectively signaling: “This
discount is too steep.”

WHAT TO WATCH NEXT:
For BBWI, the market will want to see stabilization, especially
around margins, inventory discipline, and forward guidance. If the
company can deliver even modestly better-than-feared results, a stock
that has been punished could see a sharper-than-expected rebound.
Insider buying suggests leadership believes the risk/reward is
improving from the levels where they stepped in.

-------------------------

_Market Crux_

BEFORE CELH SOARED, THE SIGNALS FLASHED
[[link removed]]

When Celsius (CELH) was still trading under $5, the early signals were
there—volume spikes, momentum building, sector buzz. Months later,
it became one of the market's biggest stories.

That's the power of spotting small-caps before the crowd notices.

Our newest alert highlights companies showing similar early signs
right now.
CLICK HERE TO GRAB YOUR FREE SMALL-CAP ALERT.
[[link removed]]
_(By clicking the link above, you agree to opt-in to receive
communications from Market Crux)_

-------------------------

COMPANY: FISERV (SYM: FISV)
OVERSOLD, UNDER PRESSURE… AND EXECUTIVES BOUGHT AGGRESSIVELY

Finally, consider FISERV (SYM: FISV).

Just weeks ago, the stock gapped down dramatically, from about $130 to
a recent low near $60. While it’s still trying to pivot higher, the
move left the stock severely oversold and sparked a wave of investor
concern.

The decline followed the company cutting its growth forecast and
earnings outlook, and noting that operations in Argentina could be
hurt by poor economic conditions. The selloff was severe enough that
the stock fell below $100 for the first time since 2003, according to
Barron’s.

But after that selloff, we saw meaningful insider buying:

*
CFO PAUL TODD BOUGHT 17,000 SHARES FOR ROUGHLY $1 MILLION.

*
CHIEF ADMINISTRATIVE AND LEGAL OFFICER ADAM ROSMAN BOUGHT 7,900 SHARES
FOR ABOUT $499,201.

This is the classic “buying into fear” setup, insiders stepping in
after a sharp repricing event, when sentiment is washed out and
expectations have been reset lower.

In a situation like this, the market usually transitions from panic to
a more measured evaluation: How much of the bad news is now priced in?
Is this a temporary reset, or something structurally worse?

Insiders buying heavily right after guidance cuts can be a meaningful
tell. It doesn’t guarantee an immediate rebound, but it does suggest
EXECUTIVES BELIEVE THE MARKET REACTION OVERSHOT THE REALITY, and that
the business is worth materially more than the post-gap valuation
implies.

WHAT TO WATCH NEXT:
With FISV, the focus is on whether fundamentals stabilize and whether
management can rebuild credibility with clearer execution and outlook.
If that happens, oversold conditions plus insider buying can become a
powerful combination for a snapback rally.

-------------------------

_Crypto 101_

THE CRASH DIDN'T KILL THIS CRYPTO. IT MADE IT STRONGER.
[[link removed]]

The crypto crash we just went through? It was a stress test.

Projects with weak fundamentals got exposed. Overleveraged traders got
liquidated. Paper hands got shaken out at the worst possible moment.

But a few cryptos passed the test with flying colors.

I'm WATCHING ONE RIGHT NOW
[[link removed]]
that actually saw its on-chain metrics IMPROVE during the carnage. 

More network activity. More active addresses. More real usage… while
prices collapsed around it.

That's not luck. That's underlying strength that the market hasn't
priced in yet.

Now that the selling pressure is finally lifting, this disconnect
won't last long.

Our track record speaks for itself… 

8,600% (OCEAN) 
3,500% (PRE) 
1,743% (ALBT)

SEE THE CRYPTO THAT EMERGED FROM THE CRASH STRONGER THAN EVER… GO
HERE NOW.
[[link removed]]

The shakeout separated the pretenders from the contenders. I know
which side I'm betting on.

-------------------------

_Are there any other stocks with insider buying you've heard about
recently? What other sectors of the market are you currently
interested in? Hit "reply" to this email and let us know your
thoughts!_

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431

Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the
Markets. For more information about our privacy practices, please
review our Privacy Policy
[[link removed]]
or our Legal Notices.
[[link removed]]

Behind the Markets
[[link removed]]

Unsubscribe
[[link removed]]

invisiblelink
[[link removed]]